List of Aspen Unscrambler Customers
Bedford, 1730, MA,
United States
Since 2010, our global team of researchers has been studying Aspen Unscrambler customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Aspen Unscrambler for Asset Performance Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Aspen Unscrambler for Asset Performance Management include: Thermo Fisher Scientific, a United States based Life Sciences organisation with 125000 employees and revenues of $42.88 billion, GSK, a United Kingdom based Life Sciences organisation with 69310 employees and revenues of $42.21 billion, Ferring Pharmaceuticals, a Switzerland based Life Sciences organisation with 6000 employees and revenues of $2.28 billion and many others.
Contact us if you need a completed and verified list of companies using Aspen Unscrambler, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Aspen Unscrambler customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Ferring Pharmaceuticals | Life Sciences | 6000 | $2.3B | Switzerland | AspenTech | Aspen Unscrambler | Asset Performance Management | 2021 | n/a |
In 2021, Ferring Pharmaceuticals deployed Aspen Unscrambler as part of AspenTech's Process Analytical Technology solution to prototype continuous manufacturing with closed-loop control. Ferring Pharmaceuticals used Aspen Unscrambler to provide PAT analytics for process monitoring and model driven decisioning across its global manufacturing footprint in Europe and the United States.
The implementation centered on Aspen Unscrambler for multivariate data analysis and chemometrics, building predictive models for process variables and product quality, with model validation and deployment pipelines configured to feed inference into control loops. Aspen Unscrambler was used alongside Aspen Process Pulse to enable model scoring in near real time, supporting real time release testing and automated adjustments to maintain critical quality attributes.
Integration was executed within the AspenTech PAT stack, with Aspen Unscrambler exchanging analytic outputs with Aspen Process Pulse to close the control loop on unit operations. Operational coverage included pilot and production sites in Europe and the US, with impacts concentrated on manufacturing and quality functions as processes shifted from batch sequencing toward continuous flows.
Rollout followed a prototyping led approach that aligned analytic governance and model lifecycle controls with quality and release protocols. The case study documents PAT enabled closed loop control, a smaller facility footprint versus batch operations, and explicit outcomes of reduced cost of goods sold and accelerated time to market from the Aspen Unscrambler implementation.
|
 |
GSK | Life Sciences | 69310 | $42.2B | United Kingdom | AspenTech | Aspen Unscrambler | Asset Performance Management | 2023 | n/a |
In 2023, GSK implemented Aspen Unscrambler in EMEA and the UK for product quality monitoring in pharmaceutical manufacturing, Apps Category . The deployment was executed to detect pH probe issues in bioreactors and to reduce the risk of costly batch loss, with documentation of Aspen Unscrambler usage recorded in the AspenTech case study.
The Aspen Unscrambler implementation centered on chemometric and multivariate analysis capabilities, including spectral analysis, principal component analysis and multivariate statistical process control workflows to identify anomalous probe behavior. Configuration focused on model development and automated monitoring pipelines, enabling early detection rules and alarm logic that feed into operational response procedures.
The solution was integrated with Aspen Process Pulse to consume bioreactor pH probe telemetry and to orchestrate real time monitoring across GSK sites in the UK and EMEA. Operational ownership spanned manufacturing and quality functions, with governance configured to route alerts to process control and quality assurance teams. The implementation produced an early detection outcome that prevented an estimated $5M USD in drug substance waste and is referenced in the AspenTech case study as an example of Aspen Unscrambler applied to bioprocess pH monitoring.
|
 |
Thermo Fisher Scientific | Life Sciences | 125000 | $42.9B | United States | AspenTech | Aspen Unscrambler | Asset Performance Management | 2020 | n/a |
In 2020 Thermo Fisher Scientific implemented Aspen Unscrambler, Apps Category "". The deployment is described in the context of AspenTech’s process analytical technology portfolio and aligns with AspenTech examples where Aspen Process Pulse was applied for PAT in solid-dose continuous manufacturing in the Americas, United States.
Aspen Unscrambler was used within the same PAT narrative to support chemometric model development and multivariate analysis, supporting spectral preprocessing, calibration model building, and multivariate statistical process control workflows. The implementation focused on embedding analytical model outputs into production monitoring, consistent with common Aspen Unscrambler capabilities for model maintenance, validation, and batch or continuous data analysis.
Operationally the work covered solid-dose continuous manufacturing in the Americas and connected analytical model outputs into process control, drawing on AspenTech statements that Aspen Process Pulse fed real-time outputs into process control for improved product quality and productivity. Aspen Unscrambler usage is inferred as part of the same AspenTech PAT portfolio to generate the multivariate model outputs consumed by Process Pulse and operational control systems.
Governance and rollout emphasized analytical model governance and the operationalization of PAT workflows at manufacturing sites for solid-dose production, with model handoff into process control loops. According to AspenTech commentary the combined deployment delivered better process control and reduced total cost of supply, and AspenTech specifically cites improved product quality and productivity for this customer example.
|
Buyer Intent: Companies Evaluating Aspen Unscrambler
- Brander Group, a United States based Professional Services organization with 25 Employees
- University of Foggia, a Italy based Education company with 719 Employees
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||